Studies Link Dynamic ctDNA Monitoring to Treatment Response in Gastroesophageal and Rectal Cancers
Studies in gastroesophageal and locally advanced rectal cancers linked dynamic ctDNA monitoring to treatment response and prognosis. MRD clearance, more than 90% ctDNA declines, and early ctDNA clearance were associated with better outcomes.